LONG-ACTING BRONCHODILATORS ARE THE KEY OF THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Abstract

Long-acting bronchodilators are themain treatment choice of stable chronic obstructive pulmonary disease (COPD). Depending on phenotype and severity of COPD, it is important to select not only the most appropriate medication, start
treatment on the time, but also choose the most suitable inhaler. The clinical trials demonstrated the good effect of tiotropium monotherapy in reducing COPD symptoms and especially ratio of exacerbations. Combination of tiotropium/ olodaterol have showed the benefit improving lung function, reducing symptoms, hyperinflation, increasing physical activity and endurance, reducing exacerbations of COPD, confirmed the safety and better life quality. Reusable inhaler Respimat® is unique inhaler which provides high lung deposition, environmentally friendly and ensure 24 hour acting bronchodilation for patients with COPD. Opportunity to use the same inhaler with 6 cartridges will help significantly reduce environmental pollution.